What is the effectiveness and safety of mirtazapine versus escitalopram in alleviating cancer-associated poly-symptomatology (the MIR-P study)? A mixed-method randomized controlled trial protocol

Peer Review reports

Original Submission
23 Apr 2021	Submitted	Original manuscript
5 May 2022	Author responded	Author comments - Guillaume Pierre, Serge Economos
Resubmission - Version 2
5 May 2022	Submitted	Manuscript version 2
Publishing
11 May 2022	Editorially accepted
23 May 2022	Article published	10.1186/s12904-022-00976-7

Back to article page